![]() |
![]() |
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
(51) | INT.CL. | A61K 31/4412 | (2006.01) |
A61K 31/496 | (2013.01) | ||
A61K 31/496 | (2006.01) | ||
A61K 31/4412 | (2013.01) | ||
A61K 45/06 | (2006.01) | ||
A61K 45/06 | (2013.01) | ||
A61P 11/00 | (2006.01) | ||
A61P 11/00 | (2018.01) |
(11) | Patento numeris | 3930715 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 20710607.1 |
Europos patento paraiškos padavimo data | 2020-02-26 | |
(97) | Europos patento paraiškos paskelbimo data | 2022-01-05 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2024-05-08 |
(46) | Apibrėžties vertimo paskelbimo data |
(86) | Numeris | PCT/IB2020/051642 |
Data | 2020-02-26 |
(87) | Numeris | WO 2020/174420 |
Data | 2020-09-03 |
(30) | Numeris | Data | Šalis |
201962811009 P | 2019-02-27 | US |
(72) |
COUSENS, Leslie , US
NIVENS, Chad , US
ESCOTT, Katherine Jane , GB
MONKLEY, Susan , SE
PRASSE, Antje , DE
|
(73) |
Astrazeneca AB ,
151 85 Södertälje,
SE
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. , Hansastr. 27c, 80686 München, DE |
(54) | SARACATINIB FOR USE IN THE TREATMENT OF IDIOPATHIC PULMONARY FIBROSIS |
SARACATINIB FOR USE IN THE TREATMENT OF IDIOPATHIC PULMONARY FIBROSIS |